Addison’s Disease Drugs Market Analysis: Size, Share, and Projected 10.6% CAGR by 2031 Increasing awareness of adrenal insufficiency and advancements in pharmaceuticals are fueling momentum in the Addison’s Disease Drugs Market. Addison’s disease, a rare condition caused by deficient cortisol and aldosterone secretion, requires lifelong medication to prevent serious complications, including adrenal crisis. Traditionally managed through hormone replacement therapy, the...
0 Поделились
13 Просмотры
0 предпросмотр